Key insights
- A retail investor expresses concerns about Abbott's recent performance, citing underperforming baby formula sales, pending lawsuits, and a large acquisition. While acknowledging the company's strong position in glucose monitoring and medical devices like MitraClip, the investor seeks feedback on their investment. The overall tone suggests a slightly bearish outlook due to immediate headwinds, but a belief in the company's long-term potential.
I bought around a month ago, Currently down 18%. Im. Not worried I know they just spent billions on an acquisition of Exact sciences. have pending lawsuits along with lawsuits that have a judgement. Baby formula is preforming poorly. It’s down 35% YTD. The most recent earnings report met but didn’t beat. It’s FWD P/E is 15 and is about 22 % lower than the other companies like them but obviously there are competitors with better numbers and are bigger. I have a belief in them, glucose monitoring is booming and there medical devices pretty good MitraClip holds over 60% of the market. I’d like some constructive criticism and I’m sure I will be clowned for owning this stock but that’s what Reddit is for. Let me know what you think.